That is a fair point, in that it is asking how this will be tested. We will come to those points because we are going to deal, to some degree, with
medical testing and how it is possible to license some of these drugs so that they can continue to be tested. We were talking earlier about how universities and research institutions can continue testing on drugs such as cannabis. That is a key point: that testing will go on. I will make sure about that before Report.